Business Description
Guardion Health Sciences Inc
NAICS : 325412
SIC : 2833
ISIN : US40145Q5009
Description
Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.9 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.33 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 52.8 | |||||
3-Year EPS without NRI Growth Rate | 54.5 | |||||
3-Year FCF Growth Rate | 50.4 | |||||
3-Year Book Growth Rate | -38.9 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 96.99 | |||||
9-Day RSI | 94.43 | |||||
14-Day RSI | 91.55 | |||||
6-1 Month Momentum % | 15.13 | |||||
12-1 Month Momentum % | 24.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.68 | |||||
Quick Ratio | 16.59 | |||||
Cash Ratio | 16.16 | |||||
Days Inventory | 135.18 | |||||
Days Sales Outstanding | 60.23 | |||||
Days Payable | 41.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward Dividend Yield % | 108.93 | |||||
3-Year Average Share Buyback Ratio | -61.4 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.07 | |||||
Operating Margin % | -41.23 | |||||
Net Margin % | 68.21 | |||||
FCF Margin % | -41.93 | |||||
ROE % | 79.19 | |||||
ROA % | 49.82 | |||||
ROIC % | -126.39 | |||||
ROC (Joel Greenblatt) % | -131.26 | |||||
ROCE % | -33.77 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.64 | |||||
Price-to-Owner-Earnings | 3.52 | |||||
PS Ratio | 2.45 | |||||
PB Ratio | 1.68 | |||||
Price-to-Tangible-Book | 2.79 | |||||
EV-to-EBIT | -3.31 | |||||
EV-to-EBITDA | -3.33 | |||||
EV-to-Revenue | 1.37 | |||||
EV-to-FCF | -4.52 | |||||
Price-to-Net-Current-Asset-Value | 2.79 | |||||
Price-to-Net-Cash | 2.88 | |||||
Earnings Yield (Greenblatt) % | -30.2 | |||||
FCF Yield % | -21.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guardion Health Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.647 | ||
EPS (TTM) (€) | 4.631 | ||
Beta | 0.87 | ||
Volatility % | 91.93 | ||
14-Day RSI | 91.55 | ||
14-Day ATR (€) | 0.700235 | ||
20-Day SMA (€) | 8.86 | ||
12-1 Month Momentum % | 24.11 | ||
52-Week Range (€) | 4.54 - 16.5 | ||
Shares Outstanding (Mil) | 1.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guardion Health Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guardion Health Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Guardion Health Sciences Inc Frequently Asked Questions
What is Guardion Health Sciences Inc(STU:0QTA)'s stock price today?
The current price of STU:0QTA is €16.50. The 52 week high of STU:0QTA is €16.50 and 52 week low is €4.54.
When is next earnings date of Guardion Health Sciences Inc(STU:0QTA)?
The next earnings date of Guardion Health Sciences Inc(STU:0QTA) is 2024-11-14 Est..
Does Guardion Health Sciences Inc(STU:0QTA) pay dividends? If so, how much?
Guardion Health Sciences Inc(STU:0QTA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |